| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
| mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.24 |
0.001 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.002 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |